Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)

NCT02959905 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Solid Cancer

Interventions

BIOLOGICAL: TSA-CTL
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

BGI, China

Collaborators

[object Object]